Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00309413
Show Display Options
Download search resultsDownload the search results for:
NCT00309413 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed A Clinical Trial on the Antipsychotic Properties of Cannabidiol
Conditions: Schizophrenia;   Psychotic Disorders
Interventions: Drug: Placebo/Cannabidiol;   Drug: Cannabidiol/Placebo

Study has passed its completion date and status has not been verified in more than two years.